Chronic Myelomonocytic Leukemia — Trials

Chronic Myelomonocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 86
Recruiting: 51
Ph III recruiting: 3
Growth YoY: —
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04358393	A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS	unknown	Phase 1 / Phase 2	69	Ascentage Pharma Group Inc.INDUSTRY	1	Feb 1, 2024	clinicaltrials
NCT05970822	Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML	unknown	Phase 1	32	Biocity Biopharmaceutics Co., Ltd.INDUSTRY	1	Aug 1, 2023	clinicaltrials